Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Financing
Sort By
Newest First
Sign in
1 / 24
1 / 24
Announcement
NorthX Biologics Appoints Patrick DePalma Senior Vice President of North American Business Development
NorthX Biologics
PR-01-25-NI-22
Jan 20, 2025
Business
Samsung Biologics presents business updates at 2025 J.P. Morgan Healthcare Conference
Samsung Biologics
PR-01-25-NI-17
Jan 16, 2025
Acquirement
Lilly to Acquire Scorpion Therapeutics' Mutant-Selective PI3Kα Inhibitor Program
Eli Lilly and Company
PR-01-25-NI-14
Jan 14, 2025
Antibody
Timberlyne Therapeutics Secures $180M Series A to Advance CM313, a Promising Anti-CD38 Antibody for High-Need Diseases.
Timberlyne Therapeutics
PR-01-25-NI-07
Jan 10, 2025
Investment
Samsung Invests in Generate: Biomedicines to Advance AI-Driven Protein Therapeutics Discovery
Samsung Biologics
PR-12-24-NI-141
Dec 18, 2024
sustainability
Samsung Biologics Listed Among Top Most Sustainable Companies in Dow Jones Sustainability World Index
Samsung Biologics
PR-12-24-NI-138
Dec 17, 2024
Announcement
Theravance Biopharma to Conduct Investor Meetings During the J.P. Morgan 43rd Annual Healthcare Conference
Theravance Biopharma
PR-12-24-NI-137
Dec 17, 2024
Announcement
Amgen Announces $1 Billion Manufacturing Expansion in North Carolina
Amgen
PR-12-24-NI-129
Dec 06, 2024
Acquisition
Ampersand Capital Partners Aquired Nektar Therapeutics' PEG Reagent Manufacturing Business, Launching Newly Branded Gannet BioChem
Ampersand Capital Partners
PR-12-24-NI-121
Dec 02, 2024
Financing
EQT Life Sciences leads €54 Million Series A Financing of ATB Therapeutics
EQT
PR-11-24-NI-116
Nov 20, 2024
biotechnology
Atlas Venture targets $450M for 14th biotech fund, the same size as its 2022 raise
Atlas Venture
PR-11-24-NI-111
Nov 18, 2024
Axonics
Boston Scientific Closes Acquisition of Axonics, Inc.
Boston Scientific
PR-11-24-NI-105
Nov 15, 2024
Supply Chain
Frontier Scientific Solutions Unveils Plans for a Trade Zone Gateway Dedicated for Life Sciences Supply Chain
Frontier Scientific Solutions
PR-10-24-NI-98
Nov 15, 2024
Announcement
Bio-Techne To Present At Investor Conferences
Bio-Techne Corporation
PR-10-24-NI-87
Nov 08, 2024
Financing
Microbiologics Acquires SensID, Expanding Expertise in Diagnostic Quality Controls
Microbiologics
PR-10-24-NI-76
Nov 06, 2024
Financing
Artificial Intelligence in Biotechnology Market to Hit USD 7.75 Billion by 2029 with 19.1% CAGR | MarketsandMarkets™
MarketsandMarkets™
PR-10-24-NI-67
Oct 29, 2024
Financing
AbbVie to Acquire Aliada Therapeutics, Strengthening Focus in Alzheimer's Disease and Neuroscience Pipeline
AbbVie
PR-10-24-NI-65
Oct 29, 2024
Announcement
SK bioscience Announces Approval of Its Quadrivalent Influenza Vaccine in Indonesia
SK bioscience
PR-10-24-NI-59
Oct 23, 2024
Financing
mRNA Synthesis & Manufacturing Market to Hit USD 738.3 Million by 2029 with 3.4% CAGR | MarketsandMarkets™
MarketsandMarkets™
PR-10-24-NI-50
Oct 17, 2024
Financing
Why Life Science Companies Surged amid a Global M&A Downturn
Amanda Wang
That's Nice LLC
PAO-10-24-CL-11
Oct 15, 2024
